Appendix A

References

ADNI (Alzheimer’s Disease Neuroimaging Initiative). 2010. ADNI publications. http://www.adni-info.org/scientists/adniscientistshome/adnipublications.aspx (accessed February 1, 2013).

Alzheimer’s Association. 2012. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 8(2):131-168. http://www.alz.org/downloads/facts_figures_2012.pdf (accessed February 1, 2013).

Alzheimer’s Association Expert Advisory Workgroup on the National Alzheimer’s Project Act [NAPA]. 2012. Workgroup on NAPA’s scientific agenda for a national initiative on Alzheimer’s disease. Alzheimer’s & Dementia 8:357-371.

Arrasate, M., and S. Finkbeiner. 2005. Automated microscope system for determining factors that predict neuronal fate. Proceedings of the National Academy of Sciences of the United States of America 102(10):3840-3845.

Asuni, A. A., A. Boutajangout, D. Quartermain, and E. M. Sigurdsson. 2007. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. Journal of Neuroscience 27(34):9115-9129.

Bertram, L., and R. E. Tanzi. 2005. The genetic epidemiology of neurodegenerative disease. Journal of Clinical Investigation 115(6):1449-1457.

Bilican, B., A. Serio, S. J. Barmada, A. L. Nishimura, G. J. Sullivan, M. Carrasco, H. P. Phatnani, C. A. Puddifoot, D. Story, J. Fletcher, I. H. Park, B. A. Friedman, G. Q. Daley, D. J. Wyllie, G. E. Hardingham, I. Wilmut, S. Finkbeiner, T. Maniatis, C. E. Shaw, and S. Chandran. 2012. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proceedings of the National Academy of Sciences of the United States of America 109(15):5803-5808.

Boimel, M., N. Grigoriadis, A. Lourbopoulos, E. Haber, O. Abramsky, and H. Rosenmann. 2010. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Experimental Neurology 224(2):472-485.

Boutajangout, A., D. Quartermain, and E. M. Sigurdsson. 2010. Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. Journal of Neuroscience 30(49):16559-16566.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 69
Appendix A References ADNI (Alzheimer’s Disease Neuroimaging Initiative). 2010. ADNI publications. http://www. adni-info.org/scientists/adniscientistshome/adnipublications.aspx (accessed February 1, 2013). Alzheimer’s Association. 2012. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 8(2):131-168. http://www.alz.org/downloads/facts_figures_2012.pdf (accessed February 1, 2013). Alzheimer’s Association Expert Advisory Workgroup on the National Alzheimer’s Project Act [NAPA]. 2012. Workgroup on NAPA’s scientific agenda for a national initiative on Alzheimer’s disease. Alzheimer’s & Dementia 8:357-371. Arrasate, M., and S. Finkbeiner. 2005. Automated microscope system for determining factors that predict neuronal fate. Proceedings of the National Academy of Sciences of the United States of America 102(10):3840-3845. Asuni, A. A., A. Boutajangout, D. Quartermain, and E. M. Sigurdsson. 2007. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. Journal of Neuroscience 27(34):9115-9129. Bertram, L., and R. E. Tanzi. 2005. The genetic epidemiology of neurodegenerative disease. Journal of Clinical Investigation 115(6):1449-1457. Bilican, B., A. Serio, S. J. Barmada, A. L. Nishimura, G. J. Sullivan, M. Carrasco, H. P. Phatnani, C. A. Puddifoot, D. Story, J. Fletcher, I. H. Park, B. A. Friedman, G. Q. Daley, D. J. Wyllie, G. E. Hardingham, I. Wilmut, S. Finkbeiner, T. Maniatis, C. E. Shaw, and S. Chandran. 2012. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proceedings of the National Academy of Sciences of the United States of America 109(15):5803-5808. Boimel, M., N. Grigoriadis, A. Lourbopoulos, E. Haber, O. Abramsky, and H. Rosenmann. 2010. Efficacy and safety of immunization with phosphorylated tau against neurofibril- lary tangles in mice. Experimental Neurology 224(2):472-485. Boutajangout, A., D. Quartermain, and E. M. Sigurdsson. 2010. Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. Journal of Neuroscience 30(49):16559-16566. 69

OCR for page 69
70 NEURODEGENERATION Braak, H., and E. Braak. 1991. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 82(4):239-259. Brecht, W. J., F. M. Harris, S. Chang, I. Tesseur, G. Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, R. W. Mahley, and Y. Huang. 2004. Neuron-specific apolipopro- tein e4 proteolysis is associated with increased tau phosphorylation in brains of trans- genic mice. Journal of Neuroscience 24(10):2527-2534. Cai, Q., H. M. Zakaria, A. Simone, and Z.-H. Sheng. 2012. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Current Biology 22(6):545-552. Castilla, J., P. Saá, C. Hetz, and C. Soto. 2005. In vitro generation of infectious scrapie prions. Cell 121(2):195-206. Chai, X., S. Wu, T. K. Murray, R. Kinley, C. V. Cella, H. Sims, N. Buckner, J. Hanmer, P. Davies, M. J. O’Neill, M. L. Hutton, and M. Citron. 2011. Passive immunization with anti-tau antibodies in two transgenic models: Reduction of tau pathology and delay of disease progression. Journal of Biological Chemistry 286(39):34457-34467. Cooper, T. A., L. Wan, and G. Dreyfuss. 2009. RNA and disease. Cell 136(4):777-793. Coskun, P. E., M. F. Beal, and D. C. Wallace. 2004. Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replica- tion. Proceedings of the National Academy of Sciences of the United States of America 101(29):10726-10731. Coskun, P. E., J. Wyrembak, O. Derbereva, G. Melkonian, E. Doran, I. T. Lott, E. Head, C. W. Cotman, and D. C. Wallace. 2010. Systemic mitochondrial dysfunction and the etiology of Alzheimer’s disease and Down syndrome dementia. Journal of Alzheimer’s Disease 20(Suppl 2):S293-S310. Cuervo, A. M., L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer. 2004. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305(5688):1292-1295. de Calignon, A., M. Polydoro, M. Suárez-Calvet, C. William, D. H. Adamowicz, K. J. Kopeikina, R. Pitstick, N. Sahara, K. H. Ashe, G. A. Carlson, T. L. Spires-Jones, and B. T. Hyman. 2012. Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 73(4):685-697. de Lau, L. M., and M. M. Breteler. 2006. Epidemiology of Parkinson’s disease. Lancet Neu- rology 5(6):525-535. Di Pardo, A., V. Maglione, M. Alpaugh, M. Horkey, R. S. Atwal, J. Sassone, A. Ciammola, J. S. Steffan, K. Fouad, R. Truant, and S. Sipione. 2012. Ganglioside GM1 induces phos- phorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proceedings of the National Academy of Sciences of the United States of America 109(9):3528-3533. Diaz-Espinoza, R., and C. Soto. 2010. Generation of prions in vitro and the protein-only hypothesis. Prion 4(2):53-59. Faghihi, M. A., F. Modarresi, A. M. Khalil, D. E. Wood, B. G. Sahagan, T. E. Morgan, C. E. Finch, G. St. Laurent, and P. J. Kenny. 2008. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nature Medicine 14(7):723-730. Fouillet, A., C. Levet, A. Virgone, M. Robin, P. Dourlen, J. Rieusset, E. Belaidi, M. Ovize, M. Touret, S. Nataf, and B. Mollereau. 2012. ER stress inhibits neuronal death by promoting autophagy. Autophagy 8(6):915-926. Galasko, D. R., E. Peskind, C. M. Clark, J. F. Quinn, J. M. Ringman, G. A. Jicha, C. Cotman, B. Cottrell, T. J. Montine, R. G. Thomas, P. Aisen, for the Alzheimer’s Disease Coopera- tive Study. 2012. Antioxidants for Alzheimer’s disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology 69(7):836-841.

OCR for page 69
appendix a 71 Gohil, V. M., N. Offner, J. A. Walker, S. A. Sheth, E. Fossale, J. F. Gusella, M. E. MacDonald, C. Neri, and V. K. Mootha. 2011. Meclizine is neuroprotective in models of Huntington’s disease. Human Molecular Genetics 20(2):294-300. Hara, T., K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, R. Suzuki-Migishima, M. Yokoyama, K. Mishima, I. Saito, H. Okano, and N. Mizushima. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441(7095):885-889. Hebert, L. E., P. A. Scherr, J. L. Bienias, D. A. Bennett, and D. A. Evans. 2003. Alzheimer disease in the U.S. population: Prevalence estimates using the 2000 Census. Archives of Neurology 60(8):1119-1122. Hetz, C., A.-H. Lee, D. Gonzalez-Romero, P. Thielen, J. Castilla, C. Soto, and L. H. Glimcher. 2008. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 105(2):757-762. Hetz, C., P. Thielen, S. Matus, M. Nassif, F. Court, R. Kiffin, G. Martinez, A. M. Cuervo, R. H. Brown, and L. H. Glimcher. 2009. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes & Development 23(19):2294-2306. Hua, Y., K. Sahashi, F. Rigo, G. Hung, G. Horey, C. F. Bennett, and A. R. Krainer. 2011. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478(7367):123-126. IOM (Institute of Medicine). 2013. Improving the utility and translation of animal models for nervous system disorders: Workshop summary. Washington, DC: The National Academies Press. http://www.nap.edu/catalog.php?record_id=13530 (accessed February 1, 2013). Irwin, D. J., J. Y. Abrams, L. B. Schonberger, E. Werber Leschek, J. L. Mills, V. M.-Y. Lee, and J. Q. Trojanowski. 2013. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol- ogy 70(4):462-468. Ju, S., D. F. Tardiff, H. Han, K. Divya, Q. Zhong, L. E. Maquat, D. A. Bosco, L. J. Hayward, R. H. Brown, Jr., S. Lindquist, D. Ringe, and G. A. Petsko. 2011. A yeast model of FUS- TLS-dependent cytotoxicity. PLoS Biology 9(4):e1001052. Jucker, M., and L. C. Walker. 2011. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Annals of Neurology 70(4):532-540. Karbowski, M., and A. Neutzner. 2012. Neurodegeneration as a consequence of failed mito- chondrial maintenance. Acta Neuropathologica 123(2):157-171. Komatsu, M., S. Waguri, T. Chiba, S. Murata, J. Iwata, I. Tanida, T. Ueno, M. Koike, Y. Uchiyama, E. Kominami, and K. Tanaka. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441(7095):880-884. Koob, M. D., M. L. Moseley, L. J. Schut, K. A. Benzow, T. D. Bird, J. W. Day, and L. P. Ranum. 1999. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nature Genetics 21(4):379-384. Kwiatkowski, T. J., D. A. Bosco, A. L. Leclerc, E. Tamrazian, C. R. Vanderburg, C. Russ, A. Davis, J. Gilchrist, E. J. Kasarskis, T. Munsat, P. Valdmanis, G. A. Rouleau, B. A. Hosler, P. Cortelli, P. J. de Jong, Y. Yoshinaga, J. L. Haines, M. A. Pericak-Vance, J. Yan, N. Ticozzi, T. Siddique, D. McKenna-Yasek, P. C. Sapp, H. R. Horvitz, J. E. Landers, and R. H. Brown. 2009. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205-1208. Lagier-Tourenne, C., M. Polymenidou, and D. W. Cleveland. 2010. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Human Molecular Genetics 19(R1):R46-R64.

OCR for page 69
72 NEURODEGENERATION Lee, B. H., M. J. Lee, S. Park, D. C. Oh, S. Elasser, P. C. Chen, C. Gartner, N. Dimova, J. Hanna, S. P. Gygi, S. M. Gygi, S. M. Wilson, R. W. King, and D. Finley. 2010a. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467(7312):179-184. Lee, J. H, W. H. Yu, A. Kumar, S. Lee, P. S. Mohan, C. M. Peterhoff, D. M. Wolfe, M. Martinez-Vicente, A. C. Massey, G. Sovak, Y. Uchiyama, D. Westaway, A. M. Cuervo, and R. A. Nixon. 2010b. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141(7):1146-1158. Lee, S. J., H. S. Lim, E. Masliah, and H. J. Lee. 2011. Protein aggregate spreading in neuro- degenerative diseases: Problems and perspectives. Neuroscience Research 70(4):339-348. Lee, V. M.-Y., and J. Q. Trojanowski. 2006. Mechanisms of Parkinson’s disease linked to pathological α-synuclein: New targets for drug discovery. Neuron 52:33-38. Lim, Y., V. M. Kehm, C. Li, J. Q. Trojanowski, and V. M. Lee. 2010. Forebrain overexpres- sion of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption. Experimental Neurology 221(1):86-97. Lin, M. T., and M. F. Beal. 2006. Mitochondrial dysfunction and oxidative stress in neurode- generative diseases. Nature 443(7113):787-795. Liu, L., V. Drouet, J. W. Wu, M. P. Witter, S. A. Small, C. Clelland, and K. Duff. 2012. Trans- synaptic spread of tau pathology in vivo. PLoS One 7(2):e31302. Luk, K. C., E. G., Hyde, J. Q. Trojanowski, and V. M. Lee. 2007. Sensitive fluorescence po- larization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors. Biochemistry 46(44):12522-12529. Luk, K. C., V. M. Kehm, B. Zhang, P. O’Brien, J. Q. Trojanowski, and V. M. Lee. 2012. Intra- cerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurode- generative α-synucleinopathy in mice. Journal of Experimental Medicine 209(5):975-986. Magrané, J., M. A. Sahawneh, S. Przedborski, A. G. Estévez, and G. Manfredi. 2012. Mito- chondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. Journal of Neuroscience 32(1):229-242. Manczak, M., T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy. 2006. Mitochondria are a direct site of Abeta accumulation in Alzheimer’s disease neurons: Implications for free radical generation and oxidative damage in disease progression. Human Molecular Genetics 15(9):1437-1449. Manfredi, G., and Z. Xu. 2005. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5(2):77-87. Martin, L. J. 2010. Mitochondrial and cell death mechanisms in neurodegenerative diseases. Pharmaceuticals (Basel, Switzerland) 3(4):839-915. Martinez-Vicente, M., Z. Talloczy, E. Wong, G. Tang, H. Koga, S. Kaushik, R. de Vries, E. Arias, S. Harris, D. Sulzer, and A. M. Cuervo. 2010. Cargo recognition failure is responsi- ble for inefficient autophagy in Huntington’s disease Nature Neuroscience 13(5):567-576. Mattick, J. S. 2007. A new paradigm for developmental biology. Journal of Experimental Biology 210(Pt 9):1526-1547. Matus, S., L. H. Glimcher, and C. Hetz. 2011. Protein folding stress in neurodegenerative diseases: A glimpse into the ER. Current Opinion in Cell Biology 23:239-252. Meyer-Luehmann, M., J. Coomaraswamy, T. Bolmont, S. Kaeser, C. Schaefer, E. Kilger, A. Neuenschwander, D. Abramowski, P. Frey, A. L. Jaton, J. M. Vigouret, P. Paganetti, D. M. Walsh, P. M. Mathews, J. Ghiso, M. Staufenbiel, L. C. Walker, and M. Jucker. 2006. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313(5794):1781-1784. Michikawa, Y., F. Mazzucchelli, N. Bresolin, G. Scarlato, and G. Attardi. 1999. Aging- dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286(5440):774-779.

OCR for page 69
appendix a 73 Morales, R., C. Duran-Aniotz, J. Castilla, L. D. Estrada, and C. Soto. 2011. De novo induction of amyloid-β deposition in vivo. Molecular Psychiatry 17(12):1347-1353. Morimoto, R. 2012. Proteostasis challenge by neurodegenerative diseases. Slides presented at the Institute of Medicine Workshop on Neurodegeneration: Opportunities for Collabo- ration Across Disease-Specific Research and Development Communities, Washington, DC. http://iom.edu/~/media/Files/Activity%20Files/Research/NeuroForum/2012-APR-30/ Presentations/morimoto-4-12.pdf (accessed August 6, 2013). Murphy, D. D., S. M. Rueter, J. Q. Trojanowski, and V. M. Lee. 2000. Synucleins are devel- opmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. Journal of Neuroscience 20(9):3214-3220. Narendra, D. P., and R. J. Youle. 2011.Targeting mitochondrial dysfunction: Role for PINK1 and Parkin in mitochondrial quality control. Antioxidants and Redox Signaling 14(10):1929-1938. NIH Blueprint (National Institutes of Health Blueprint for Neuroscience Research). 2013. Blueprint Neurotherapeutics Network. http://neuroscienceblueprint.nih.gov/bpdrugs (ac- cessed May 28, 2013). NINDS (National Institute of Neurological Disorders and Stroke). 2012. NINDS Coopera- tive Program in Translational Research (U01). http://grants.nih.gov/grants/guide/pa-files/ PAR-13-022.html (accessed May 28, 2013). NINDS. 2013. NeuroNEXT. http://www.neuronext.org (accessed May 28, 2013). Pagliarini, D. J., S. E. Calvo, B. Chang, S. A. Sheth, S. B. Vafai, S. E. Ong, G. A. Walford, C. Sugiana, A. Boneh, W. K. Chen, D. E. Hill, M. Vidal, J. G. Evans, D. R. Thorburn, S. A. Carr, and V. K. Mootha. 2008. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134(1):112-123. Passini, M. A., J. Bu, A. M. Richards, C. Kinnecom, S. P. Sardi, L. M. Stanek, Y. Hua, F. Rigo, J. Matson, G. Hung, E. M. Kaye, L. S. Shihabuddin, A. R. Krainer, C. F. Bennett, and S. H. Cheng. 2011. Antisense oligonucleotides delivered to the mouse CNS ame- liorate symptoms of severe spinal muscular atrophy. Science Translational Medicine 3(72):72ra18. PDF (Parkinson’s Disease Foundation). 2012. Statistics on Parkinson’s. http://www.pdf.org/ en/parkinson_statistics (accessed January 20, 2013). Pedrini, S., D. Sau, S. Guareschi, M. Bogus, R. H. Brown, N. Naniche, A. Kia, D. Trotti, and P. Pasinelli. 2010. ALS-linked mutant SOD1 damages mitochondria by promoting con- formational changes in Bcl-2. Human Molecular Genetics 19(15):2974-2986. Polymenidou, M., C. Lagier-Toureene, K. R. Hutt, S. C. Huelga, J. Moran, T. Y. Liang, S. C. Ling, E. Sun, E. Wancewicz, C. Mazur, H. Kordasiewicz, Y. Sedaghat, J. P. Donohus, L. Shiue, C. F. Bennett, G. W. Yeo, and D. W. Cleveland. 2011. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neuroscience 14(4):459-468. Qureshi, I. A., and M. F. Mehler. 2011. Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends in Molecular Medicine 17(6):337-346. Ranum, L. P., and T. A. Cooper. 2006. RNA-mediated neuromuscular disorders. Annual Review of Neuroscience 29:259-277. Ravikumar, B., R. Duden, and D. C. Rubinsztein. 2002. Aggregate-prone proteins with poly- glutamine and polyalanine expansions are degraded by autophagy. Human Molecular Genetics 11(9):1107-1117. Reddy, P. H., and T. P. Reddy. 2011. Mitochondria as a therapeutic target for aging and neu- rodegenerative diseases. Current Alzheimer Research 8(4):393-409. Reitz, C., C. Brayne, and R. Mayeux. 2011. Epidemiology of Alzheimer’s disease. Nature Reviews Neurology 7(3):137-152.

OCR for page 69
74 NEURODEGENERATION Selkoe, D. J. 2008. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behavioral Brain Research 192:106-113. Serio, A., B. Bilican, S. J. Barmada, D. M. Ando, C. Zhao, R. Siller, K. Burr, G. Haghia, D. Storya, A. L. Nishimurad, M. A. Carrascoe, H. P. Phatnanie, C. Shumd, I. Wilmuta, T. Maniatise, C. E. Shawd, S. Finkbeiner, and S. Chandrana. 2013. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proceedings of the National Academy of Sciences of the United States of America 110(12):4697-4702. Sharma, P., D. M. Ando, A. Daub, J. A. Kaye, and S. Finkbeiner. 2012. High-throughput screening in primary neurons. Methods in Enzymology 506:331-360. Song, W., J. Chen, A. Pertrilli, G. Liot, E. Klinglmayr, Y. Zhou, P. Poquiz, J. Tjong, M. A. Pouladi, M. R. Hayden, E. Masliah, M. Ellisman, I. Rouiller, R. Schwarzenbacher, B. Bossy, G. Perkins, and E. Bossy-Wetzel. 2011. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nature Medicine 17(3):377-382. Soto, C., L. Estrada, and J. Castilla. 2006. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends in Biochemical Sciences 31(3):150-155. Spires-Jones, T. L., W. H. Stoothoff, A. de Calignon, P. B. Jones, and B. T. Hyman. 2009. Tau pathophysiology in neurodegeneration: a tangled issue. Trends in Neuroscience 32:150-159. Taft, R. J., K. C. Pang, T. R. Mercer, M. Dinger, and J. S. Mattick. 2010. Non-coding RNAs: Regulators of disease. Journal of Pathology 220(2):126-139. Tofaris, G. K., H. T. Kim, R. Hourez, J. W. Jung, K. P. Kim, and A. L. Goldberg. 2011. Ubiq- uitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proceedings of the National Academy of Sciences of the United States of America 108(41):17004-17009. Trojanowski, J. Q. 2012. Introduction to session 4: Neurodegenerative disease transmission and immune therapy. Slides presented at the Institute of Medicine Workshop on Neurode- generation: Opportunities for Collaboration Across Disease-Specific Research and Devel- opment Communities, Washington, DC. http://iom.edu/~/media/Files/Activity%20Files/ Research/NeuroForum/2012-APR-30/Presentations/Trojanowski_Introduction%20 To%20Session%204_Final.pdf (accessed June 12, 2013). Trottier, Y., Y. Lutz, G. Stevanin, G. Imbert, D. Devys, G. Cancel, F. Saudou, C. Weber, G. David, L. Tora, Y. Agid, A. Brice, and J.-L. Mandel. 1995. Polyglutamine expansion as a pathological epitope in Huntington’s disease and four dominant cerebellar ataxias. Nature 378:403-406. Tsvetkov, A. S., J. Miller, M. Arraste, J. S. Wong, M. A. Pleiss, and S. Finkbeiner. 2010. A small-molecule scaffold induces autophagy in primary neurons and protects against toxic- ity in a Huntington disease model. Proceedings of the National Academy of Sciences of the United States of America 107(39):16982-16987. Umeda, T., T. Tomiyama, N. Sakama, S. Tanaka, M. P. Lambert, W. L. Klein, and H. Mori. 2011. Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. Journal of Neuroscience Research 89(7):1031-1042. Vance, C., B. Rogelj, T. Hortobágyi, K. J. De Vos, A. L. Nishimura, J. Sreedharan, X. Hu, B. Smith, D. Ruddy, P. Wright, J. Ganesalingam, K. L. Williams, V. Tripathi, S. Al-Saraj, A. Al-Chalabi, P. N. Leigh, I. P. Leigh, G. Nicholson, J. de Belleroche, J. M. Gallo, C. C. Miller, and C. E. Shaw. 2009. Mutations in FUS, an RNA processing protein, cause fa- milial amyotrophic lateral sclerosis type 6. Science 323(5918):1208-1211.

OCR for page 69
appendix a 75 Vidal, R. L., A. Figueroa, F. A. Court, P. Thielen, C. Molina, C. Wirth, B. Caballero, R. Kiffin, J. Segura-Aguilar, A. M. Cuervo, L. H. Glimcher, and C. Hetz. 2012. Targeting the UPR transcription factor XBP1 protects against Huntington’s disease through the regulation of FoxO1 and autophagy. Human Molecular Genetics 21(10):2245-2262. Voisine, C., J. S. Pedersen, and R. I. Morimoto. 2010. Chaperone networks: Tipping the bal- ance in protein folding diseases. Neurobiology of Diseases 40(1):12-20. Volpicelli-Daley, L. A., K. C. Luk, T. P. Patel, S. A. Tanik, D. M. Riddle, A. Stieber, D. F. Meaney, J. Q. Trojanowski, and V. M. Lee. 2011. Exogenous α-synuclein fibrils in- duce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57-71. Vossel, K. A., K. Zhang, J. Brodbeck, A. C. Daub, P. Sharma, S. Finkbeiner, B. Cui, and L. Mucke. 2010. tau reduction prevents Abeta-induced defects in axonal transport. Science 330(6001):198. Wallace, D. C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annual Review of Genetics 39:359-407. Wallace, D. C. 2010. Mitochondrial DNA mutations in disease and aging. Environmental and Molecular Mutagenesis 51:440-450. Wang, F., X. Wang, C.-G. Yuan, and J. Ma. 2010. Generating a prion with bacterially ex- pressed recombinant prion protein. Science 327(5969):1132-1135. Wang, X., and C. T. Moraes. 2011. Increases in mitochondrial biogenesis impair carcinogen- esis at multiple levels. Molecular Oncology 5(5):399-409. Wang, X., D. Winter, G. Ashrafi, J. Schlehe, Y. L. Wong, D. Selkoe, S. Rice, J. Steen, M. J. LaVoie, and T. L. Schwarz. 2011. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147(4):893-906. WHO (World Health Organization). 2012. Dementia: A public health priority. http://whqlib doc.who.int/publications/2012/9789241564458_eng.pdf (accessed February 1, 2013). Williams, A. J., and H. L. Paulson. 2008. Polyglutamine neurodegeneration: Protein misfold- ing revisited. Trends in Neuroscience 31:521-528. Williams, A., L. Jahreiss, S. Sarkar, S. Saiki, F. M. Menzies, B. Ravikumar, and D. C. Rubinsztein. 2006. Aggregate-prone proteins are cleared from the cytosol by autophagy: Therapeutic implications. Current Topics in Developmental Biology 76:89-101. Wolfe, K. J., and D. M. Cyr. (2011). Amyloid in neurodegenerative diseases: Friend or foe? Seminars in Cellular & Developmental Biology 22(5):476-481. Yamada, K., J. R. Cirrito, F. R. Stewart, H. Jiang, M. B. Finn, B. B. Holmes, L. I. Binder, E. M. Mandelkow, M. I. Diamond, V. M. Lee, and D. M. Holtzman. 2011. In vivo microdialy- sis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. Journal of Neuroscience 31(37):13110-13117. Yang, Z., and D. J. Klionsky. 2010. Eaten alive: A history of macroautophagy. Nature Cell Biology 12(9):814-822. Yao, J., R. W. Irwin, L. Zhao, J. Nilsen, R. T. Hamilton, and R. D. Brinton. 2009. Mito- chondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proceedings of the National Academy of the Sciences of the United States of America 106(34):14670-14675. Young, A. B. 2009. Four decades of neurodegenerative disease research: How far we have come! Journal of Neuroscience 29(41):12722-12728. Zu, T., B. Gibbens, N. S. Doty, M. Gomes-Pereira, A. Huguet, M. D. Stone, J. Margolis, M. Peterson, T. W. Markowski, M. A. Ingram, Z. Nan, C. Foster, W. C. Low, B. Schose, N. V. Somia, H. B. Clark, S. Schmechel, P. B. Bitterman, G. Gourdon, M. S. Swanson, M. Moseley, and L. P. Ranum. 2011. Non-ATG-initiated translation directed by microsatel- lite expansions. Proceedings of the National Academy of Sciences of the United States of America 108(1):260-265.

OCR for page 69
76 NEURODEGENERATION Zuleta, A., R. L. Vidal, D. Armentano, G. Parsons, and C. Hetz. 2012. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggrega- tion in a mouse model of Huntington’s disease. Biochemical and Biophysical Research Communications 420(3):558-563.